Leaderboards/Congenital Heart Disease Studies

Congenital Heart Disease Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

Mohammad Moltafet

University of Oulu

Vincent Gonzalez

Nebraska Medical Center

Mohamed A. Abd-Elmagid

The Ohio State University

Filip Eckerström

Sahlgrenska University Hospital

Marielle C. Young

Massachusetts General Hospital

Jill P. J. M. Hikspoors

Maastricht University

Aisa Zulibiya

Xinjiang Uygur Autonomous Region Disease Prevention and Control Center

Eiri Kisamori

NewYork–Presbyterian Hospital

Yutao Chen

Wuhan University of Technology

Anusha Konduri

Southwestern Medical Center

Papers

Publication in Journal of Thoracic and Cardiovascular Surgery (2024) [28 citations, W4395960781]

Journal of Thoracic and Cardiovascular Surgery|2024

28 cit.

Publication in IEEE/ACM Transactions on Networking (2024) [11 citations, W4395069505]

IEEE/ACM Transactions on Networking|2024

11 cit.

Publication in European Heart Journal - Quality of Care and Clinical Outcomes (2024) [6 citations, W4390631665]

European Heart Journal - Quality of Care and Clinical Outcomes|2024

6 cit.

Human Cardiac Development

Advances in experimental medicine and biology|2024

5 cit.

Publication in Journal of the American Heart Association (2024) [5 citations, W4404045615]

Journal of the American Heart Association|2024

5 cit.

Publication in The Annals of Thoracic Surgery (2025) [5 citations, W4414825315]

The Annals of Thoracic Surgery|2025

5 cit.

Evaluating safety and length of unit stay associated with 1-bag chemotherapy desensitization

The Journal of Allergy and Clinical Immunology In Practice|2024

4 cit.

On the Semantic Security in the General Bounded Storage Model: A New Proof

IEEE Transactions on Information Forensics and Security|2024

2 cit.

Publication in Pediatric Cardiology (2025) [2 citations, W4412030515]

Pediatric Cardiology|2025

2 cit.

Publication (2025) [2 citations, W4415366757]

Unknown Journal|2025

2 cit.

Emerging Leaders

Drafting the new consensus

Papers

Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021

The Lancet Haematology|2023

666 cit.

Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021

The Lancet Haematology|2023

551 cit.

Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet|2025

278 cit.

An Exploratory Study of EFL Learners’ Use of ChatGPT for Language Learning Tasks: Experience and Perceptions

Languages|2023

254 cit.

Adults With Congenital Heart Disease: Trends in Event-Free Survival Past Middle Age

Circulation|2022

126 cit.

One year of AU Mic with HARPS – II. Stellar activity and star–planet interaction

Monthly Notices of the Royal Astronomical Society|2022

64 cit.

Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021

The Lancet|2024

64 cit.

Prevalence and Prognostic Implications of Left Ventricular Systolic Dysfunction in Adults With Congenital Heart Disease

Journal of the American College of Cardiology|2022

46 cit.

Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-Fontan

Journal of the American College of Cardiology|2023

43 cit.

Exercise-Induced Changes in Pulmonary Artery Wedge Pressure in Adults Post-Fontan Versus Heart Failure with Preserved Ejection Fraction and Non-Cardiac Dyspnoea

European Journal of Heart Failure|2022

38 cit.

Current Senior Leaders

Wrote the book, still writing it

Papers

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

European Heart Journal|2015

7k cit.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

European Respiratory Journal|2015

3.2k cit.

A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy

Cell|1998

2.6k cit.

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

Circulation|2008

2.1k cit.

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

Circulation|2004

1.9k cit.

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

Proceedings of the National Academy of Sciences|2008

1.8k cit.

The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis

Developmental Cell|2008

1.8k cit.

Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study

The Lancet|2000

1.8k cit.

Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA

Science|2007

1.7k cit.

Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council

Journal of the American Society of Echocardiography|2010

1.5k cit.

Reagents for Congenital Heart Disease Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 70

cGAS (E5V3W) Rabbit Monoclonal Antibody (BSA and Azide Free)

#86793$865

View Evidence →

Cell Signaling TechnologyEvidence 64

PathScan® Sandwich ELISA Lysis Buffer (1X)

#7018$58

View Evidence →

Cell Signaling TechnologyEvidence 65

SARS-CoV-2 Spike Protein (RBD) Matched Antibody Pair

#92221$1,726

View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

PathScan® RP GST-Tag Sandwich ELISA Kit

Cited in 7 papers

#73605$67,830,490

View Evidence →

Cell Signaling TechnologyEvidence 65

DLST (D22G7) Rabbit Monoclonal Antibody

Monoclonal Anti-Actin (alpha-Sarcomeric) antibody produced in mouse

#A2172

View Evidence →